MARSH & MCLENNAN COMPANIES, INC.·4

Feb 26, 4:43 PM ET

MCGIVNEY MARK C 4

Research Summary

AI-generated summary

Updated

Marsh & McLennan (MRSH) CFO Mark McGivney Receives Equity Awards

What Happened
Mark C. McGivney, Chief Financial Officer of Marsh & McLennan Companies (MRSH), was granted equity awards on February 24, 2026 totaling 62,704 derivative shares: 44,743 stock options and 17,961 restricted stock units (resulting from performance stock units). Both grants show $0.00 per share (no cash purchase). The options vest in four equal annual installments (Feb 24 of 2027–2030); the restricted stock units reflect the payout of 2023–2025 performance stock units as of Feb 24, 2026.

Key Details

  • Transaction date: February 24, 2026; Form 4 filed Feb 26, 2026.
  • Grants: 44,743 options @ $0.00 (derivative); 17,961 RSUs/PSU conversion @ $0.00 (derivative). Total granted = 62,704 shares.
  • Vesting: Options vest in four equal annual installments on Feb 24 of 2027, 2028, 2029 and 2030 (Footnote F1).
  • Conversion: The RSUs/PSU payout converts to common stock on a 1-for-1 basis (F2); these RSUs reflect performance PSUs granted Feb 23, 2023 for the 2023–2025 period, with the performance factor determined Feb 24, 2026 (F3).
  • Tax withholding / other: Footnote F4: Not applicable.
  • Shares owned after transaction: Not specified in this Form 4.
  • Timeliness: Form reports transactions dated Feb 24, 2026 and was filed Feb 26, 2026 (no late-filing flag shown in the filing details provided).

Context
These entries are grants/award-related derivative transactions (options and performance-linked RSUs), not open-market purchases or sales. Grants are compensation and long-term incentives and do not represent an immediate cash outlay or sale of shares; they typically vest over time or convert based on performance. Retail investors should view awards as part of executive compensation rather than direct insider buying or selling.